Table 1 Demographic and clinical characteristics at baseline (n = 738).
Total | PWV < 1,400 cm/s (n = 259) | PWV ≥ 1,400 cm/s (n = 479) | P value | |
|---|---|---|---|---|
Age | 51.6 ± 4.9 | 49.8 ± 4.5 | 52.5 ± 4.8 | <0.01 |
Male, n (%) | 208 (28.2%) | 47 (18.1%) | 161 (33.6%) | <0.01 |
Tobacco intake, n (%) | 127 (17.2%) | 37 (14.3%) | 90 (18.8%) | 0.12 |
Alcohol intake, n (%) | 170 (23.0%) | 54 (20.8%) | 116 (24.2%) | 0.30 |
BMI, kg/m2 | 25.7 ± 3.3 | 25.2 ± 3.1 | 25.9 ± 3.2 | <0.01 |
Total cholesterol, mmol/L | 5.29 ± 0.93 | 5.20 ± 0.91 | 5.33 ± 0.94 | 0.06 |
HDL-C, mmol/L | 1.48 ± 0.39 | 1.56 ± 0.40 | 1.44 ± 0.39 | <0.01 |
LDL-C, mmol/L | 3.19 ± 0.77 | 3.10 ± 0.73 | 3.24 ± 0.79 | 0.01 |
Triglycerides, mmol/L* | 1.58 ± 1.49 | 1.32 ± 1.05 | 1.72 ± 1.67 | <0.01 |
FBG, mmol/L | 5.89 ± 1.36 | 5.59 ± 1.06 | 6.06 ± 1.47 | <0.01 |
Serum creatinine, μmol/L | 56.5 ± 12.0 | 54.3 ± 9.3 | 57.7 ± 13.0 | <0.01 |
Hypertension, n (%) | 256 (34.7%) | 27 (10.4%) | 229 (47.8%) | <0.01 |
Systolic blood pressure, mmHg | 128.9 ± 14.9 | 120.2 ± 11.5 | 133.6 ± 14.4 | <0.01 |
Diastolic blood pressure, mmHg | 75.4 ± 9.5 | 71.8 ± 7.8 | 77.4 ± 9.7 | <0.01 |
Diabetes mellitus, n (%) | 114 (15.4%) | 22 (8.5%) | 92 (19.2%) | <0.01 |
Heart rate, bpm | 74.0 ± 11.4 | 71.2 ± 11.2 | 75.4 ± 11.2 | <0.01 |
Dyslipidemia, n (%) | 496 (67.2%) | 154 (59.5%) | 342 (71.4%) | <0.01 |
Anti-hypertension medicine, n (%) | 146 (19.9%) | 15 (5.8%) | 131 (27.5%) | <0.01 |
Anti-diabetes medicine, n (%) | 49 (6.6%) | 9 (3.5%) | 40 (8.4%) | 0.01 |
Lipid-lowering medicine, n (%) | 41 (5.6%) | 6 (2.3%) | 35 (7.4%) | <0.01 |
Self-reported CVD history, n (%) | 49 (6.6%) | 15 (5.8%) | 34 (7.1%) | 0.496 |
ba-PWV, cm/s | 1,516 ± 263 | 1,263 ± 96 | 1,653 ± 219 | <0.01 |
